BRIEF published on 06/18/2026 at 09:35, 2 months 7 days ago AATec Medical dévoilera les données de l'ATL-105 lors de sa conférence de 2026. ATL-105 Données Précliniques Bronchectasie Traitement Multimodal Essai De Phase 1/2
BRIEF published on 06/18/2026 at 09:35, 2 months 7 days ago AATec Medical to Unveil ATL-105 Data at 2026 Conference Preclinical Data ATL-105 Phase 1/2 Trial Bronchiectasis Multimodal Treatment
PRESS RELEASE published on 06/18/2026 at 09:30, 2 months 7 days ago AATec to Present Data from Lead Candidate ATL-105 at World Bronchiectasis Conference 2026 AATec to present preclinical data on lead candidate ATL-105 at World Bronchiectasis Conference 2026, demonstrating multimodal effects for non-CF bronchiectasis treatment Respiratory Diseases Preclinical Data ATL-105 Bronchiectasis AATec
BRIEF published on 07/15/2025 at 09:05, 1 year 1 month ago AATec Medical et Northway Biotech forment un partenariat pour le développement de la production d'ATL-105 Partenariat ATL-105 Fabrication De Produits Biologiques Maladies Pulmonaires Thérapie Respiratoire
BRIEF published on 07/15/2025 at 09:05, 1 year 1 month ago AATec Medical and Northway Biotech Form Partnership for ATL-105 Production Development Partnership ATL-105 Biologics Manufacturing Lung Diseases Respiratory Therapy
PRESS RELEASE published on 07/15/2025 at 09:00, 1 year 1 month ago AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Diseases AATec Medical and Northway Biotech announce partnership to develop industrial production process for ATL-105 targeting lung diseases Partnership AATec Medical ATL-105 Lung Diseases Northway Biotech
BRIEF published on 04/15/2025 at 11:09, 1 year 4 months ago AATec Medical Secures EUR 4 Million for Respiratory Drug Development Biotechnology Funding Clinical Trials Drug Development Respiratory Diseases
BRIEF published on 04/15/2025 at 11:09, 1 year 4 months ago AATec Medical obtient 4 millions d'euros pour le développement de médicaments respiratoires Biotechnologie Financement Essais Cliniques Développement De Médicaments Maladies Respiratoires
PRESS RELEASE published on 04/15/2025 at 11:04, 1 year 4 months ago AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development AATec Medical secures EUR 4 million funding to advance lead respiratory drug candidate, ATL-105, for clinical development to treat non-CF bronchiectasis by 2026 Clinical Development AATec Medical Non-CF Bronchiectasis EUR 4 Million Respiratory Drug Candidate
BRIEF published on 09/18/2024 at 10:05, 1 year 11 months ago AATec Medical accueille le professeur James Chalmers au sein de son conseil consultatif scientifique AATec Medical Conseil Consultatif Scientifique James Chalmers Bronchectasie AAT Recombinante
Published on 08/26/2026 at 09:05, 13 minutes ago BioNxt Advances Cladribine Clinical Program for MS with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies
Published on 08/25/2026 at 23:05, 10 hours 13 minutes ago Faraday Copper Shareholders Approve Share Issuance in Connection with the Acquisition of the San Manuel Project
Published on 08/25/2026 at 15:00, 18 hours 18 minutes ago Four Nines Gold Intersects Hydrothermal Breccia in First Three Holes at Hayden Hill
Published on 08/25/2026 at 14:30, 18 hours 48 minutes ago First Breach Completes First Flight of Drone Prototype and Advances American-Made Manufacturing Through Hellbender Agreement
Published on 08/26/2026 at 09:08, 10 minutes ago Private Assets combines Kieler Maschinenwerke and Pro-Valve into Kiel Power Systems SE
Published on 08/26/2026 at 09:05, 12 minutes ago ROHM Introduces 650V IGBTs, Achieving Industry-leading Low-loss Characteristics
Published on 08/26/2026 at 09:00, 17 minutes ago Original-Research: Emerald Horizon AG (von NuWays AG): BUY
Published on 08/26/2026 at 08:05, 1 hour 12 minutes ago Sylvox to Showcase All-Season Outdoor Entertainment Across Three Experience Zones at IFA 2026
Published on 08/25/2026 at 17:45, 15 hours 33 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 15 hours 33 minutes ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
Published on 08/25/2026 at 17:45, 15 hours 33 minutes ago Imerys-08-2026-communique-capital-droits-de-vote-au-31-juilet-2026
Published on 08/25/2026 at 08:30, 1 day ago Eiffage wins several contracts worth a total of €132 million in the healthcare sector
